ClearPoint Neuro, Inc. Announces First Procedure Utilizing ClearPoint 2.0 Software in Europe
IRVINE, Calif., Jan. 14, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today reported the first utilization in Europe of its Version 2.0 software, together with the ClearPoint Neuro Navigation System, at Rigshospitalet in Copenhagen, Denmark. The procedure, which took place last week, also represents the first European site to use the ClearPoint System under live MRI guidance for navigation of a laser catheter in the brain.
"ClearPoint offers a stereotactic system based on MRI localization with an MRI compatible frame. My clear impression, after my first-time experience, is that the system offers superior accuracy of the stereotactic procedure as compared to our standard frame with CT localization," stated Rune Rasmussen, MD, PhD, Head of Stereotactics at Rigshospitalet. "With a small tumor target and a very challenging anatomy and vasculature, having the ability to perform this case with ClearPoint under live MRI guidance provided us with great confidence that our placement of the catheter was no less than optimal. An additional advantage is the on-site stereotactic support from very competent representatives."